Brian J. Bolwell

Hematology | Oncology

9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.

Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.

Journal: Leukemia

Published: December 17, 2023

Authentic leadership at the Cleveland Clinic: psychological safety in the midst of crisis.

Authentic leadership at the Cleveland Clinic: psychological safety in the midst of crisis.

Journal: BMJ leader

Published: April 14, 2022

Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.

Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.

Journal: Transplantation and cellular therapy

Published: June 28, 2021

Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.

Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: February 12, 2020

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study.

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study.

Journal: JNCI cancer spectrum

Published: October 14, 2019

Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma.

Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: June 25, 2019

Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: June 21, 2019

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Journal: Hematology/oncology and stem cell therapy

Published: May 21, 2019

Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.

Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.

Journal: Journal of oncology practice

Published: April 23, 2019

Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study.

Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study.

Journal: PloS one

Published: April 05, 2019

Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.

Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.

Journal: Hematology/oncology and stem cell therapy

Published: February 20, 2019

BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.

BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: December 18, 2018

Showing 1-12 of 73

Last Updated: 09/26/2026